-
CSCO 2024 | Dr. Yilong Wu: How to Make Targeted Therapy Decisions for NSCLC Patients with EGFR Mutations
The 27th National Conference on Clinical Oncology and the 2024 CSCO Annual Meeting, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was held from September 25 to 29, 2024, in Xiamen. During the conference, several forums on lung cancer covered cutting-edge research and developments in the…
-
CSCO 2024丨Dr. Jun Ma Reflects on CSCO’s Glorious Journey: China’s Rise in Oncology on the Global Stage
From September 25-29, 2024, the “27th National Clinical Oncology Conference and 2024 CSCO Annual Meeting,” hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, will be held in Xiamen. With the theme “Patient-Centered, Sharing the Future,” the conference will showcase major research advancements and developments in the…
-
CUA 2024 | Dr. Eamonn Rogers: Patient-Centered Care and Exploring Future Strategies for Prostate Cancer
Prostate cancer is a common malignant tumor in elderly men. However, with continuous advancements in diagnostic and treatment strategies, patient survival rates have improved, and patient-centered care has become a key focus in oncology. During the recent CUA Annual Meeting, Urology Frontier invited Dr. Eamonn Rogers from the National University of Ireland to share his…
-
CUA 2024 | Dr. Jeremy Teoh: Addressing Unmet Needs in NMIBC and Exploring Advanced Diagnostic and Treatment Strategies
Bladder cancer is one of the most common malignant tumors among the Chinese population, with 75% of cases classified as non-muscle invasive bladder cancer (NMIBC), which has a high postoperative recurrence rate. What are the unmet diagnostic and treatment needs of NMIBC patients? Which research findings may change future clinical practice for NMIBC? During the…
-
ESMO 2024丨Dr. Fufu Zheng: Progress in Urologic Cancer Research and Explorations Likely to Change Clinical Practice for Advanced Renal Cancer
The 2024 European Society for Medical Oncology (ESMO) Annual Meeting is being held from September 13-17 in Barcelona, Spain. Several key studies in the field of urologic cancers have attracted significant attention at the conference. Urology Frontier invited Dr. Fufu Zheng from the Department of Urology at The First Affiliated Hospital , Sun Yat-sen University…
-
Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis
Study Overview: The study analyzed the clinical characteristics of 283 AIH patients who underwent liver biopsies at Ruijin Hospital between January 2016 and February 2022. Prevalence of MADs in AIH…
-
Dr. Yonghong Xiao: From Concept to Action, Implementing One Health Strategies and Multidisciplinary Cooperation | Chairperson Interview
01 Infectious Diseases Frontier: Congratulations on the successful conclusion of this conference. Compared to the first conference, what changes or innovations did this year’s event introduce in terms of content,…
-
Revolutionizing NSCLC Treatment: Dr. Baohui Han and Dr. Mitsudomi Unveil New Frontiers in Immunotherapy Strategies
The 27th National Clinical Oncology Conference and 2024 CSCO Academic Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing CISCO Clinical Oncology Research Foundation, took place in Xiamen from September 25 to 29, 2024. During this event, Dr. Tetsuya Mitsudomi, who has led several large-scale immunotherapy clinical trials, gave an academic…
Connecting Medical Expertise through Media